Latest Sands Capital Ventures, LLC Stock Portfolio
$421Million– No. of Holdings #21
Sands Capital Ventures, LLC Performance:
2026 Q1: -28.46%YTD: -28.46%2025: 21.76%
Performance for 2026 Q1 is -28.46%, and YTD is -28.46%, and 2025 is 21.76%.
About Sands Capital Ventures, LLC and 13F Hedge Fund Stock Holdings
Sands Capital Alternatives, LLC is a hedge fund based in Arlington, VA. On 2026-05-08, the fund reported it's updated stock portfolio. In the 13F Holdings report, Sands Capital Alternatives, LLC reported an equity portfolio of $421.2 Millions as of 31 Mar, 2026.
The top stock holdings of Sands Capital Alternatives, LLC are NU, , . The fund has invested 22.3% of it's portfolio in NU HLDGS LTD and 16.9% of portfolio in KLAVIYO INC.
They significantly reduced their stock positions in NU HLDGS LTD (NU). Sands Capital Alternatives, LLC opened new stock positions in SPYGLASS PHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to SAMSARA INC (IOT), DOORDASH INC (DASH) and COUPANG INC (CPNG).
The top stock holdings of Sands Capital Alternatives, LLC are NU, , . The fund has invested 22.3% of it's portfolio in NU HLDGS LTD and 16.9% of portfolio in KLAVIYO INC.
They significantly reduced their stock positions in NU HLDGS LTD (NU). Sands Capital Alternatives, LLC opened new stock positions in SPYGLASS PHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to SAMSARA INC (IOT), DOORDASH INC (DASH) and COUPANG INC (CPNG).
Sands Capital Ventures, LLC Equity Portfolio Value
Last Reported on: 08 May, 2026
Sands Capital Ventures, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Sands Capital Alternatives, LLC made a return of -28.46% in the last quarter. In trailing 12 months, it's portfolio return was 1.25%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| spyglass pharma inc | 64,775,300 |
New stocks bought by Sands Capital Ventures, LLC
Additions
| Ticker | % Inc. |
|---|---|
| samsara inc | 20.18 |
| doordash inc | 16.33 |
| coupang inc | 16.28 |
| acumen pharmaceuticals inc | 8.87 |
| beta bionics inc | 3.86 |
Additions to existing portfolio by Sands Capital Ventures, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| nu hldgs ltd | -4.72 |
Sands Capital Ventures, LLC reduced stake in above stock
Sold off
Sector Distribution
Sands Capital Alternatives, LLC has about 69.9% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
- Consumer Cyclical
- Communication Services
| Sector | % |
|---|---|
| Others | 69.9 |
| Healthcare | 12.4 |
| Technology | 9.2 |
| Consumer Cyclical | 4.5 |
| Communication Services | 4 |
Market Cap. Distribution
Sands Capital Alternatives, LLC has about 17.7% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- LARGE-CAP
- MICRO-CAP
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 69.9 |
| LARGE-CAP | 17.7 |
| MICRO-CAP | 7.3 |
| MID-CAP | 3.8 |
| SMALL-CAP | 1.2 |
Stocks belong to which Index?
About 1.4% of the stocks held by Sands Capital Alternatives, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 98.6 |
| RUSSELL 2000 | 1.4 |
Sands Capital Ventures, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Sands Capital Ventures, LLC
Sands Capital Alternatives, LLC has 21 stocks in it's portfolio. About 87% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Sands Capital Alternatives, LLC last quarter.
Last Reported on: 08 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABOS | acumen pharmaceuticals inc | 2.08 | 3,720,100 | 8,779,450 | added | 8.87 | ||
| CADL | candel therapeutics inc | 0.47 | 405,837 | 1,988,600 | unchanged | 0.00 | ||
| CPNG | coupang inc | 4.54 | 1,012,090 | 19,108,300 | added | 16.28 | ||
| DASH | doordash inc | 3.96 | 111,231 | 16,701,300 | added | 16.33 | ||
| DDOG | datadog inc | 2.40 | 85,793 | 10,127,900 | unchanged | 0.00 | ||
| IKT | inhibikase therapeutics inc | 5.19 | 13,019,000 | 21,871,900 | unchanged | 0.00 | ||
| IOT | samsara inc | 4.22 | 560,287 | 17,755,500 | added | 20.18 | ||
| MNDY | monday com ltd | 1.11 | 67,868 | 4,690,360 | unchanged | 0.00 | ||
| NU | nu hldgs ltd | 22.30 | 6,537,770 | 93,947,700 | reduced | -4.72 | ||
| SNOW | snowflake inc | 0.72 | 20,253 | 3,054,560 | unchanged | 0.00 | ||
| TARS | tarsus pharmaceuticals inc | 1.42 | 85,000 | 5,962,750 | unchanged | 0.00 | ||
| TOST | toast inc | 1.90 | 301,647 | 7,996,660 | unchanged | 0.00 | ||
| TSHA | taysha gene therapies inc | 0.77 | 724,873 | 3,240,180 | unchanged | 0.00 | ||
| TXG | 10x genomics inc | 2.43 | 481,770 | 10,228,000 | unchanged | 0.00 | ||
| klaviyo inc | 16.86 | 3,649,680 | 71,022,700 | unchanged | 0.00 | |||
| spyglass pharma inc | 15.38 | 2,500,010 | 64,775,300 | new | ||||
| beta bionics inc | 8.82 | 3,708,040 | 37,154,600 | added | 3.86 | |||
| bioage labs inc | 3.27 | 786,353 | 13,753,300 | unchanged | 0.00 | |||
| servicetitan inc | 1.35 | 89,856 | 5,702,260 | unchanged | 0.00 | |||
| acrivon therapeutics inc | 0.70 | 2,122,600 | 2,950,420 | unchanged | 0.00 | |||